Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private

BSE5334.50-18.05 (-0.34 %)

PREV CLOSE ( ) 5352.55

OPEN PRICE ( ) 5352.55

BID PRICE (QTY) 5334.00 (20)

OFFER PRICE (QTY) 5336.90 (16)

VOLUME 54184

TODAY'S LOW / HIGH ( )5323.00 5469.60

52 WK LOW / HIGH ( )4716.75 5933

NSE5325.00-30.5 (-0.57 %)

PREV CLOSE( ) 5355.50

OPEN PRICE ( ) 5355.00

BID PRICE (QTY) 5325.50 (5)

OFFER PRICE (QTY) 5327.50 (3)

VOLUME 79487

TODAY'S LOW / HIGH( ) 5324.50 5470.00

52 WK LOW / HIGH ( )4716.2 5933.5

Quarters

Select year

( in Million)

Particulars

Mar 2026

Dec 2025

Sep 2025

Jun 2025

Audited / UnAudited

UnAudited

Net Sales

36033.2

37368.2

40009.9

33711.4

Total Expenditure

30859.3

29088.2

30802.2

26320.9

PBIDT (Excl OI)

5173.9

8280

9207.7

7390.5

Other Income

2000.7

1431

1036.9

1364.9

Operating Profit

7174.6

9711

10244.6

8755.4

Interest

538.8

421

350.2

297.8

Exceptional Items

-1349.7

-527.9

129.3

PBDT

5286.1

8762.1

9894.4

8586.9

Depreciation

1057.6

950.1

936.1

876.8

Profit Before Tax

4228.5

7812

8958.3

7710.1

Tax

1711.7

1276.7

1162.3

1026.9

Provisions and contingencies

Profit After Tax

2516.8

6535.3

7796

6683.2

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

2516.8

6535.3

7796

6683.2

Minority Interest

-146.5

-170.1

-140.5

-36.5

Shares of Associates

-5.7

-5

-4.9

-4.1

Other related items

Misc. Expenses Written off

Consolidated Net Profit

2364.6

6360.2

7650.6

6642.6

Equity Capital

239.1

Face Value (IN RS)

Reserves

Calculated EPS

19.77

53.20

63.99

55.56

Calculated EPS (Annualised)

79.11

212.80

255.97

222.25

No of Public Share Holdings

58351891

56151891

% of Public Share Holdings

48.8

46.96

PBIDTM% (Excl OI)

14.35

22.15

23.01

21.92

PBIDTM%

19.91

25.98

25.60

25.97

PBDTM%

14.67

23.44

24.72

25.47

PBTM%

11.73

20.90

22.39

22.87

PATM%

6.98

17.48

19.48

19.82

Notes

Risk Disclosures on Derivatives

Quarterly Results

ALKEM LABORATORIES LTD.